Some tips on 438049-35-5

438049-35-5 N-Boc-3-Ethylpiperazine 22219867, apiperazines compound, is more and more widely used in various fields.

438049-35-5, N-Boc-3-Ethylpiperazine is a piperazines compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

To a solution of 1, 1′-carbonyldiimidazole (468 mg, 2.80 mmol) in anhydrous DMF (2 mL) were added triethylamine (0.59 mL, 4.20 mmol) and a solution of tert-butyl 3-ethylpiperazine-1-carboxylate (500 mg, 2.33 mmol) in anhydrous DMF (2 mL) dropwise. The mixture was stirred in a sealing tube at rt for 30 min, and then anhydrous methanol (12 mL) was added. The resulting mixture was further stirred at 60 for 24 h, and concentrated. The residue was diluted with saturated aqueous NaCl (30 mL) , and extracted with EtOAc (15 mL × 2) . The combined organic layers were dried over anhydrous Na2SO4 and concentrated. The residue was purified by silica gel chromatography eluted with Petroleum ether/EtOAc (v/v) 5/1 to give 4-tert-butyl 1-methyl 2-ethylpiperazine-1, 4-dicarboxylate as colorless liquid (260 mg, 40) .1H NMR (400 MHz, CDCl3) : delta ppm 3.88-3.97 (m, 4H) , 3.70 (s, 3H) , 2.76-3.02 (m, 3H) , 1.52-1.61 (m, 2H) , 1.45 (s, 9H) , 0.89 (t, J 7.4 Hz, 3H) and MS-ESI: m/z 173.1 [M+H-100] + ., 438049-35-5

438049-35-5 N-Boc-3-Ethylpiperazine 22219867, apiperazines compound, is more and more widely used in various fields.

Reference:
Patent; SUNSHINE LAKE PHARMA CO., LTD.; ZHANG, Yingjun; LIU, Bing; YU, Tianzhu; ZHANG, Xiangyu; ZHANG, Shiguo; ZHANG, Jiancun; CHENG, Changchung; (426 pag.)WO2016/34134; (2016); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics

Analyzing the synthesis route of 438049-35-5

The synthetic route of 438049-35-5 has been constantly updated, and we look forward to future research findings.

438049-35-5, N-Boc-3-Ethylpiperazine is a piperazines compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Step 3-1, Preparation of tert-butyl (3R)-3-ethyl-4-[3-fluoro-2-(methoxycarbonyl)-4-nitrophenyl]piperazine-1-carboxylate To a solution of tert-butyl-(3R)-3-ethylpiperazine-1-carboxylate (555 mg, 2.59 mmol) and methyl 2,6-difluoro-3-nitrobenzoate (843 mg, 3.89 mmol) in DMSO (2 mL) was added DIEA (0.90 mL, 5.2 mmol). The mixture was heated at 130 C. for 1 h. The mixture was purified by C18 reversed phase column chromatography to give the title compound (813 mg, 76% yield) as a brownish yellow gum. LCMS (M+H)+: 412.3., 438049-35-5

The synthetic route of 438049-35-5 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Crinetics Pharmaceuticals, Inc.; HAN, Sangdon; ZHU, Yunfei; KIM, Sun Hee; ZHAO, Jian; WANG, Shimiao; (146 pag.)US2019/367481; (2019); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics